Sharekhan

Valiant Laboratories Ltd

Fri 11/07/2025,15:47:57 NSE: VALIANTLAB

₹ 112.09 -0.93 (-0.82%)
BUY NOW Buy Valiant Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Valiant Laboratories Ltd

Fri 11/07/2025,16:1:0

Valiant Laboratories Ltd

Fri 11/07/2025,15:47:57 | NSE : VALIANTLAB

₹ 112.09-0.93 (-0.82%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 114.84

Previous Close

₹ 113.02

Volume

18601

Mkt Cap ( Rs. Cr)

₹487.03

High

₹ 114.84

Low

₹ 111.72

52 Week High

₹ 157.49

52 Week Low

₹ 75.20

Book Value Per Share

₹ 53.31

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Valiant Laboratories Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Valiant Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Valiant Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 4:27PM Valiant Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2

  • Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Jul 2025, 4:24PM Certificate under 74(5) for the Quarter ended June 30, 2025

  • Valiant Laboratories - Updates

    10 Jul 2025, 12:43AM Valiant Laboratories Limited has informed the Exchange regarding 'Draft Letter Of Offer For Proposed Rights Issue Of Equity Shares'.

  • Valiant Laboratories - Draft Letter Of Offer For Proposed Rights Issue Of Equity Shares

    10 Jul 2025, 12:39AM Draft letter of offer for proposed rights issue of equity shares

  • Valiant Laboratories - Contact Details Of Key Managerial Personnel Of The Company Authorized Under Regulation 30(5) Of The SE

    9 Jul 2025, 6:18PM Contact details of Key Managerial Personnel of the Company authorised under Regulation 30(5) of SEBI (LODR) Regulations, 2015

  • Valiant Laboratories - General Updates

    9 Jul 2025, 6:15PM Valiant Laboratories Limited has informed the Exchange about Contact details of Key Managerial Personnel of the Company authorized under Regulation30(

  • Valiant Laboratories - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    9 Jul 2025, 12:45PM VALIANT LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfe

  • Valiant Laboratories - Change in Company Secretary/Compliance Officer

    9 Jul 2025, 12:39PM Valiant Laboratories Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

  • Valiant Laboratories - Outcome of Board Meeting

    9 Jul 2025, 12:35PM Valiant Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2025.

  • Valiant Laboratories - Outcome of Board Meeting

    9 Jul 2025, 12:26PM Valiant Laboratories Limited has informed the Exchange regarding Board meeting held on July 09, 2025, wherein the Board has considered and approved 1)

  • Valiant Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On July 09, 2025

    9 Jul 2025, 12:26PM Considered and approved 1) Fund raising via Rights Issue and 2) Appointment of the Company Secretary and Compliance Officer

  • Valiant Laboratories - Appointment of Company Secretary and Compliance Officer

    9 Jul 2025, 12:38PM Appointed Mr. Akshay Gangurde (ICSI Membership Number: A70561) as the Company Secretary and Compliance Officer of the Company with effect from July 09

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds

    9 Jul 2025, 12:29PM The board on July 09, 2025, has considered and approved raising of via Rights Issue.

  • Valiant Laboratories - Board Meeting Intimation

    5 Jul 2025, 5:12PM Valiant Laboratories Limited has informed the Exchange about Board Meeting to be held on 09-Jul-2025 to consider Fund raising.

  • Valiant Laboratories - Board Meeting Intimation for Intimation Of Board Meeting For Fund Raising

    5 Jul 2025, 5:08PM Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2025 ,inter alia, to consider

  • Valiant Laboratories - Clarification - Financial Results

    1 Jul 2025, 1:05PM The Exchange has sought clarification from Valiant Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (L

  • Valiant Laboratories - Trading Window-XBRL

    27 Jun 2025, 3:56PM VALIANT LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window

  • Valiant Laboratories - Trading Window

    27 Jun 2025, 3:54PM Valiant Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati

  • Valiant Laboratories - Credit Rating

    26 Jun 2025, 11:10AM Valiant Laboratories Limited has informed the Exchange about Credit Rating

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating

    26 Jun 2025, 11:07AM Intimation of Credit Rating received by the Company from India Ratings and Research

  • Valiant Laboratories - Disclosure under SEBI Takeover Regulations

    25 Jun 2025, 7:54PM ÿSantosh Shantilal Voraÿÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subs

  • Valiant Laboratories - Outcome of Board Meeting

    30 May 2025, 5:16PM Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Valiant Laboratories - Copy of Newspaper Publication

    22 May 2025, 1:57PM Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Valiant Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    20 May 2025, 8:02PM Resignation of Prajakta Patil as Company Secretary and Compliance Officer w.e.f. June 15, 2025.

  • Valiant Laboratories - Resignation

    20 May 2025, 7:55PM Valiant Laboratories Limited has informed the Exchange regarding Resignation of Prajakta Patil as Company Secretary & Compliance Officer of the compa

  • Valiant Laboratories - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    20 May 2025, 7:49PM VALIANT LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfe

  • Valiant Laboratories - Outcome of Board Meeting

    20 May 2025, 7:18PM Valiant Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on May 20, 2025.

  • Valiant Laboratories - Financial Results For The Quarter And Year Ended March 31, 2025

    20 May 2025, 6:03PM Financial Results for the quarter and year ended March 31, 2025

  • Valiant Laboratories posts Q4 net profit of Rs 3.24 cr

    20 May 2025, 6:01PM The company reported standalone net profit during the quarter stood at Rs 3.24 crore compared to net loss of Rs 1.22 crore in the previous year quarte

  • Valiant Laboratories - Outcome of Board Meeting

    20 May 2025, 5:43PM Valiant Laboratories Limited has informed the Exchange regarding Board meeting held on May 20, 2025.

  • Valiant Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 20, 2025.

    20 May 2025, 5:44PM Outcome of the Board Meeting dated May 20, 2025.

  • Valiant Laboratories - Board Meeting Intimation

    14 May 2025, 5:32PM VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2025 to consider and approve the Yearly Audited Financ

  • Valiant Laboratories - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving Audited Standalone

    14 May 2025, 5:09PM Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider

  • Valiant Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 8:20PM As of March 2025, 74.94% is owned by Indian Promoters and 25.06% by Public. <p align=justify> Top five Promoters holding highest number of shares of V
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Valiant Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 293.7833 296.2821 159.89 132.141
Liabilities 293.7833 296.2821 159.89 132.141
Equity 43.45 43.45 32.56 16.28
Gross Profit -4.676 -8.4083 35.09 42.318
Net Profit -2.1502 0.3403 28.998 27.496
Cash From Operating Activities -21.9012 48.7819 22.956 2.251
NPM(%) -1.61 0.18 8.68 9.43
Revenue 133.3618 182.0525 333.91 291.523
Expenses 138.0378 190.4608 298.82 249.205
ROE(%) -0.92 0.14 12.52 11.87

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Valiant Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 905.60 0.25 30.05 64.35 301.39 0.55
Lotus Eye Hospital and Institute Ltd 73.05 -1.14 208.71 234.48 3.55 0.00
Vaishali Pharma Ltd 12.76 -0.23 212.67 120.86 3.13 0.00
Astec Lifesciences Ltd 893.55 -0.53 0.00 221.12 -601.21 0.00

Company Info

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

The Company was originally formed as a partnership firm under Indian Partnership Act, 1932, under the name and style of "M/s Bharat Chemicals" pursuant to the deed of partnership dated October 17, 1980. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name "Valiant Laboratories Limited" pursuant to certificate of incorporation dated August 16, 2021 issued by Central Registration Centre, Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1,000 million2022- The annual revenue from operations crossed Rs.2,000 million- Formed the wholly owned subsidiary, VASPL to diversify the business activities

Read More

Parent Organisation

Valiant Laboratories Ltd.

Founded

06/08/2021

Managing Director

Mr.Santosh S Vora

NSE Symbol

VALIANTLABEQ

FAQ

The current price of Valiant Laboratories Ltd is ₹ 112.09.

The 52-week high for Valiant Laboratories Ltd is ₹ 114.84 and the 52-week low is ₹ 111.72.

The market capitalization of Valiant Laboratories Ltd is currently ₹ 487.03. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Valiant Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Valiant Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Valiant Laboratories Ltd shares.

The CEO of Valiant Laboratories Ltd is Mr.Santosh S Vora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT